Continuous Renal Replacement Therapy (CRRT) Market Size is Estimated to Reach USD 2.9 Billion by 2027
The global Continuous Renal Replacement Therapy (CRRT) market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 2.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 8.2% during the prediction period 2021 to 2027. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and increasing incidence of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to boost the growth of the market. Moreover, presence of well-established key players focusing on developing and commercializing technologically advanced and initiatives undertaken by government to increase the awareness about CRRT are likely to propel the market growth during the forecast period.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Continuous Renal Replacement Therapy (CRRT) market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Continuous Renal Replacement Therapy (CRRT) market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Continuous Renal Replacement Therapy (CRRT) market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Opportunities
Challenges
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Continuous Renal Replacement Therapy (CRRT) Market are:
Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), Infomed SA (Switzerland), Medtronic plc (Ireland), Medica S.p.A. (Italy), Medical Components, Inc. (US), Medites Pharma spol. s.r.o. (Czech Republic), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd. (China), Nipro Corporation (Japan), and Anjue Medical Equipment Co., Ltd. (China),
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
This research report categorizes the CRRT market based on product, modality, age group and region.
By Product
By Modality
By Age group
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits For Stakeholders
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Continuous Renal Replacement Therapy (CRRT) Market, By Age group
7.1. Continuous Renal Replacement Therapy (CRRT) Market, By Age group, 2021-2027
7.1.1. Dialysates and Replacement Fluids
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Disposables
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Hemofilters
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Bloodline Sets & Tubes
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Other Disposables
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. CRRT Systems
7.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Continuous Renal Replacement Therapy (CRRT) Market, By Age group
8.1. Continuous Renal Replacement Therapy (CRRT) Market, By Age group, 2021-2027
8.1.1. CRRT Systems
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Continuous venovenous hemodiafiltration (CVVHDF)
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Continuous venovenous haemodialysis (CVVHD)
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Slow continuous ultrafiltration (SCUF)
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Continuous Renal Replacement Therapy (CRRT) Market, By Age group
9.1. Continuous Renal Replacement Therapy (CRRT) Market, By Age group, 2021-2027
9.1.1. Adults
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Adults
9.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Continuous Renal Replacement Therapy (CRRT) Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Age group (2016-2027)
10.1.2. Market Revenue and Forecast, By Age group (2016-2027)
10.1.3. Market Revenue and Forecast, By Age group (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Age group (2016-2027)
10.1.4.2. Market Revenue and Forecast, By Age group (2016-2027)
10.1.4.3. Market Revenue and Forecast, By Age group (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Age group (2016-2027)
10.1.5.2. Market Revenue and Forecast, By Age group (2016-2027)
10.1.5.3. Market Revenue and Forecast, By Age group (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Age group (2016-2027)
10.2.2. Market Revenue and Forecast, By Age group (2016-2027)
10.2.3. Market Revenue and Forecast, By Age group (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Age group (2016-2027)
10.2.4.2. Market Revenue and Forecast, By Age group (2016-2027)
10.2.4.3. Market Revenue and Forecast, By Age group (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Age group (2016-2027)
10.2.5.2. Market Revenue and Forecast, By Age group (2016-2027)
10.2.5.3. Market Revenue and Forecast, By Age group (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Age group (2016-2027)
10.2.6.2. Market Revenue and Forecast, By Age group (2016-2027)
10.2.6.3. Market Revenue and Forecast, By Age group (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Age group (2016-2027)
10.2.7.2. Market Revenue and Forecast, By Age group (2016-2027)
10.2.7.3. Market Revenue and Forecast, By Age group (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Age group (2016-2027)
10.3.2. Market Revenue and Forecast, By Age group (2016-2027)
10.3.3. Market Revenue and Forecast, By Age group (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Age group (2016-2027)
10.3.4.2. Market Revenue and Forecast, By Age group (2016-2027)
10.3.4.3. Market Revenue and Forecast, By Age group (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Age group (2016-2027)
10.3.5.2. Market Revenue and Forecast, By Age group (2016-2027)
10.3.5.3. Market Revenue and Forecast, By Age group (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Age group (2016-2027)
10.3.6.2. Market Revenue and Forecast, By Age group (2016-2027)
10.3.6.3. Market Revenue and Forecast, By Age group (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Age group (2016-2027)
10.3.7.2. Market Revenue and Forecast, By Age group (2016-2027)
10.3.7.3. Market Revenue and Forecast, By Age group (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Age group (2016-2027)
10.4.2. Market Revenue and Forecast, By Age group (2016-2027)
10.4.3. Market Revenue and Forecast, By Age group (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Age group (2016-2027)
10.4.4.2. Market Revenue and Forecast, By Age group (2016-2027)
10.4.4.3. Market Revenue and Forecast, By Age group (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Age group (2016-2027)
10.4.5.2. Market Revenue and Forecast, By Age group (2016-2027)
10.4.5.3. Market Revenue and Forecast, By Age group (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Age group (2016-2027)
10.4.6.2. Market Revenue and Forecast, By Age group (2016-2027)
10.4.6.3. Market Revenue and Forecast, By Age group (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Age group (2016-2027)
10.4.7.2. Market Revenue and Forecast, By Age group (2016-2027)
10.4.7.3. Market Revenue and Forecast, By Age group (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Age group (2016-2027)
10.5.2. Market Revenue and Forecast, By Age group (2016-2027)
10.5.3. Market Revenue and Forecast, By Age group (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Age group (2016-2027)
10.5.4.2. Market Revenue and Forecast, By Age group (2016-2027)
10.5.4.3. Market Revenue and Forecast, By Age group (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Age group (2016-2027)
10.5.5.2. Market Revenue and Forecast, By Age group (2016-2027)
10.5.5.3. Market Revenue and Forecast, By Age group (2016-2027)
Chapter 11. Company Profiles
11.1. Baxter International Inc. (US)
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Fresenius Medical Care AG & Co. KGaA (Germany)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Fresenius Medical Care AG & Co. KGaA (Germany)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. B. Braun Melsungen AG (Germany)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Asahi Kasei Corporation (Japan)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Toray Medical Co., Ltd. (Japan)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Infomed SA (Switzerland)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Medtronic plc (Ireland)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Medica S.p.A. (Italy)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Medical Components, Inc. (US)
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers